SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Avis Budget Group, Inc. engages in the provision of vehicle sharing and rental services. It operates through the Americas and International segments. The Americas segment includes vehicle rental and car sharing operations in North America, South America, Central America, and the Caribbean. The International segment is involved in vehicle rental and car sharing operations in Europe, the Middle East, Africa, Asia, and Australasia. The company was founded in 1946 and is headquartered in Parsippany, NJ.

Avis Budget Group Inc

Avis Budget Group is experiencing a massive, sentiment-driven rally fueled by intense short squeeze dynamics, prompting the community to debate the sustainability of these record-breaking price levels. Investors are actively discussing the influence of institutional positioning and liquidity constraints, while many express caution over the stark disconnect between the stock's parabolic technical move and its underlying debt-heavy fundamentals.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble is trending as investors focus on the company's strategic acquisition of Northern Data and significant financial backing from Tether, fueling speculation about its potential as a major player in the AI cloud infrastructure space. The community is heavily focused on the stock's elevated short interest, with many traders discussing the setup for a potential short squeeze alongside growing institutional interest.

Newcourt Acquisition Corp. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on February 25, 2021 and is headquartered in Oakland, CA.

Psyence Biomedical Ltd.

Psyence Biomedical is surging as investors react to a new executive order prioritizing the development and review of psychedelic medicines, including ibogaine. The community is heavily focused on the stock's low float and high potential for a short squeeze, while also debating the firm's long-term regulatory prospects versus its current volatility.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology is trending as community members highlight a significant uptick in institutional and insider activity, alongside recent regulatory milestones like the FCA approval of its Shackleton Finance acquisition. Investors are increasingly optimistic about the company's long-term AI infrastructure pipeline, particularly the Yotta partnership in India, while debating the stock's volatility and the potential for a technical breakout.

Maase, Inc. engages in the provision of intelligent technology-driven family and enterprise services. It operates through the following business segments: Insurance Agency and Wealth Management. The Insurance Agency segment involves in providing agency services for distributing life and non-life insurance products on behalf of insurance companies. The Wealth Management segment offers financial advisory, investment planning, and asset management services for individuals, families, and corporate clients, utilizing data-driven insights and digital platforms to optimize financial outcomes. The company was founded by Hai Feng Yu on August 6, 2018, and is headquartered in Guangzhou, China.

Maase Inc. - Ordinary Shares - Class A

Highest Performances Holdings Inc. - ADR

MAAS is trending as traders speculate on a potential technical breakout driven by low-float dynamics and aggressive acquisition activity in the AI and healthcare sectors. The community is actively debating whether the stock serves as a high-upside infrastructure play or a high-risk speculative vehicle, with sentiment divided between those chasing the recent momentum and those wary of past dilution history.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is experiencing a significant surge in momentum as the stock breaks past a long-term downtrend, fueled by continued aggressive Bitcoin accumulation and the announcement of a new semi-monthly dividend structure for its preferred shares. Market participants are actively debating the sustainability of this rally, with bulls highlighting the stock's role as a levered proxy for Bitcoin's upward movement, while shorts remain under intense pressure amid a sharp increase in trading volume.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: Cybersecurity, Internet of Things (IoT), and Licensing and Other. The Cybersecurity segment includes the brand Cylance, BlackBerry Spark, AtHoc, and SecuSUITE. The IoT segment focuses on software licenses, support, maintenance, and professional services. The Licensing and Other segment involves the intellectual property licensing arrangements and settlement awards. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is trending due to a newly announced collaboration with NVIDIA that integrates its QNX safety-critical OS into advanced edge AI systems across automotive, robotics, and industrial sectors. The community is actively discussing this as a major fundamental catalyst, with many investors anticipating a significant long-term revaluation driven by growth in physical AI and enterprise demand for secure operating systems.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

COMPASS Pathways is trending following the release of statistically significant Phase 3 trial results for its COMP360 psilocybin therapy, alongside a broader market rally in the psychedelic biotech sector fueled by a presidential executive order aimed at accelerating psychedelic research and FDA review pathways. While the community is actively debating the significance of the trial data, the potential for priority review vouchers, and the possibility of future M&A activity, traders are closely monitoring liquidity and volatility as the stock reacts to these major clinical and policy catalysts.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is seeing increased investor activity driven by speculation over a potential buyout following recent consolidation in the biotech sector and significant capital infusion from Blue Owl. The community is focused on the company's Briumvi growth trajectory and the upcoming clinical data for its subcutaneous administration and Azer-cel pipeline, which many believe makes the stock an attractive target for larger pharmaceutical firms.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is seeing significant volatility after a Blue Origin launch error forced a satellite to de-orbit, prompting a sharp pre-market sell-off that the community is actively debating as a potential buying opportunity. While investors are expressing frustration over deployment delays and reliance on external launch providers, many remain bullish, framing the insurance-covered loss as a minor operational setback rather than a fundamental flaw in the company's long-term constellation strategy.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Harvard Bioscience (NASDAQ:HBIO) Director William Snider Purchases 8,475 Shares

Harvard Bioscience, Inc. (NASDAQ:HBIO - Get Free Report) Director William Snider purchased 8,475 shares of the stock in a transaction dated Tuesday, March 17th. The shares were bought at an average...

Harvard Bioscience (NASDAQ:HBIO) Director Stephen Denelsky Purchases 10,000 Shares

Harvard Bioscience, Inc. (NASDAQ:HBIO - Get Free Report) Director Stephen Denelsky acquired 10,000 shares of Harvard Bioscience stock in a transaction that occurred on Tuesday, March 17th. The shares...

Harvard Bioscience (NASDAQ:HBIO) Director William Snider Acquires 12,525 Shares

Harvard Bioscience, Inc. (NASDAQ:HBIO - Get Free Report) Director William Snider purchased 12,525 shares of the stock in a transaction dated Monday, March 16th. The stock was acquired at an average...

Insider Buying: Harvard Bioscience (NASDAQ:HBIO) Director Purchases 8,475 Shares of Stock

Harvard Bioscience, Inc. (NASDAQ:HBIO - Get Free Report) Director William Snider bought 8,475 shares of the stock in a transaction on Tuesday, March 17th. The stock was purchased at an average price...

John Duke Purchases 5,000 Shares of Harvard Bioscience (NASDAQ:HBIO) Stock

Harvard Bioscience, Inc. (NASDAQ:HBIO - Get Free Report) CEO John Duke bought 5,000 shares of the firm's stock in a transaction on Monday, March 16th. The shares were acquired at an average price of...

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. It operates under the geographical segments: United States, Germany, China, United Kingdom, and Rest of the World. It sells its products through catalog, Website, distributors, and direct sales force. The company was founded by Dr. William T. Porter in 1901 and is headquartered in Holliston, MA.

Current Price	$6.82
Prev Close	$6.13
Open	$6.06
Dividend Yield	0.00%
50-Day Moving Average	$5.37
Beta	1.84
Avg. Volume	55,422.81
PE Ratio	-0.48

52-Week High	$9.46
52-Week Low	$2.81
Market Capitalization	$27.41M
EPS (Annual)	-$12.77
Price to Book	2.00
Revenue Per Employee	$255,309.73

HBIO
Harvard Bioscience Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest HBIO News

HBIOHarvard Bioscience Inc.